Publication

Transcaval Versus Transaxillary TAVR in Contemporary Practice A Propensity-Weighted Analysis

Downloadable Content

Persistent URL
Last modified
  • 09/24/2025
Type of Material
Authors
    Robert Lederman, Emory UniversityVasilis Babaliaros, Emory UniversityJohn Lisko, Emory UniversityToby Rogers, National Heart, Lung, and Blood Institute, National Institutes of Health, BethesdaPaul Mahoney, The Sentara Heart CenterJason R Foerst, Virginia TechJeremiah P Depta, Rochester Reg HlthKamran I Muhammad, Oklahoma Heart Institute, TulsaJames M McCabe, University of WashingtonAndrei Pop, AMITA Health Alexian Brothers Medical Center, Elk Grove Village, IllinoisJaffar M Khan, National Heart, Lung, and Blood Institute, National Institutes of Health, BethesdaChristopher G Bruce, National Heart, Lung, and Blood Institute, National Institutes of Health, BethesdaGiorgio A Medranda, MedStar Washington Hospital CenterJane W Wei, Emory UniversityJose N Binongo, Emory UniversityAdam Greenbaum, Emory University
Language
  • English
Date
  • 2022-05-02
Publisher
  • ELSEVIER SCIENCE INC
Publication Version
Copyright Statement
  • Published by Elsevier on Behalf of The American College of Cardiology Foundation.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 15
Issue
  • 9
Start Page
  • 965
End Page
  • 975
Abstract
  • Objectives: The aim of this study was to compare transcaval and transaxillary artery access for transcatheter aortic valve replacement (TAVR) at experienced medical centers in contemporary practice. Background: There are no systematic comparisons of transcaval and transaxillary TAVR access routes. Methods: Eight experienced centers contributed local data collected for the STS/ACC TVT Registry (Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry) between 2017 and 2020. Outcomes after transcaval and axillary/subclavian (transaxillary) access were adjusted for baseline imbalances using doubly robust (inverse propensity weighting plus regression) estimation and compared. Results: Transcaval access was used in 238 procedures and transaxillary access in 106; for comparison, transfemoral access was used in 7,132 procedures. Risk profiles were higher among patients selected for nonfemoral access but similar among patients requiring transcaval and transaxillary access. Stroke and transient ischemic attack were 5-fold less common after transcaval than transaxillary access (2.5% vs 13.2%; OR: 0.20; 95% CI: 0.06-0.72; P = 0.014) compared with transfemoral access (1.7%). Major and life-threatening bleeding (Valve Academic Research Consortium 3 ≥ type 2) were comparable (10.0% vs 13.2%; OR: 0.66; 95% CI: 0.26-1.66; P = 0.38) compared with transfemoral access (3.5%), as was blood transfusion (19.3% vs 21.7%; OR: 1.07; 95% CI: 0.49-2.33; P = 0.87) compared with transfemoral access (7.1%). Vascular complications, intensive care unit and hospital length of stay, and survival were similar between transcaval and transaxillary access. More patients were discharged directly home and without stroke or transient ischemic attack after transcaval than transaxillary access (87.8% vs 62.3%; OR: 5.19; 95% CI: 2.45-11.0; P < 0.001) compared with transfemoral access (90.3%). Conclusions: Patients undergoing transcaval TAVR had lower rates of stroke and similar bleeding compared with transaxillary access in a contemporary experience from 8 US centers. Both approaches had more complications than transfemoral access. Transcaval TAVR access may offer an attractive option.
Author Notes
  • Robert J. Lederman, MD, Cardiovascular Branch, Division of Intramural Research, National, Heart Lung and Blood Institute, National Institutes of Health, Building 10, Room 2c713, MSC 1538, Bethesda, MD 20892-1538, Telephone: +1-301-402-6769. Email: lederman@nih.gov
Keywords

Tools

Relations

In Collection:

Items